New crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid; their use in the inhibition of 11βHSD1, processes for making them and pharmaceutical compositions comprising them are also described.
本发明涉及一种4-[4-(2-
金刚烷基
氨基甲酰)-5-叔丁基
吡唑-1-基]
苯甲酸的新晶体形式,以及它们在抑制11βH
SD1方面的用途,制造它们的过程以及包含它们的制药组合物。